Safety and efficacy of the intra-bone marrow cord blood transplantation

Safety and efficacy of the intra-bone marrow cord blood transplantation - Safety and efficacy of the intra-bone marrow cord blood transplantation

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006175

Enrollment

Registered

2011-09-30

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological diseases

Interventions

Intra-bone marrow injection of cord blood cells

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients receiving cord-blood transplantation

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Adverse effects related intra-bone injection of cord-blood cells, engraftment rate of netrophil and platelet	—

Secondary

Measure	Time frame
Regimen-related toxicity, disease-free survival, over-all survival, non-relapse mortality, relapse rate, incidence of infection, rate and severity of acute GVHD, number of neutrophil and platelet on day 50 and day 100	—

Countries

Japan

Contacts

Public ContactNaoki Kurita

University of Tsukuba Department of Hematology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026